☆ 4.7 Article

Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Combining callers improves the detection of copy number variants from whole-genome sequencing

Marie Coutelier et al.

Summary: Copy Number Variants (CNVs) are deletions, duplications, or insertions larger than 50 base pairs that contribute to normal genome variation and have significant implications in human pathology. While traditional array-based approaches have been used for CNV detection, whole-genome sequencing (WGS) offers the potential for comprehensive exploration of CNVs and smaller variants. This study evaluates practical calling options for CNV detection from WGS data, highlighting the need to strike a balance between sensitivity and sensibility. Combining multiple callers and tools like SV2 shows promising results in terms of computation time and accuracy compared to array-based methods like aCGH.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

添加到收藏夹

Review Biochemical Research Methods

Fully exploiting SNP arrays: a systematic review on the tools to extract underlying genomic structure

Laura Balague-Dobon et al.

Summary: Single nucleotide polymorphisms (SNPs) are the most common type of genomic variation and can be easily genotyped in large populations. However, individual SNPs only explain a small portion of the phenotypic differences between individuals. Genetic differences such as ancestry, collective SNP effects, structural variants, somatic mutations, and historic recombination can account for a significant proportion of genomic divergence. While characterizing these genetic differences can be infrequent or labor-intensive, many of them leave distinct markers on SNPs across the genome, allowing for their study in large population samples. Therefore, various methods have been developed to detect and analyze different genomic structures using SNP arrays in order to complement genome-wide association studies and understand the contribution of these structures to phenotypic differences between individuals. This article presents an up-to-date collection of bioinformatics tools that can be used to extract relevant genomic information from SNP array data, including population structure and ancestry, polygenic risk scores, identity-by-descent fragments, linkage disequilibrium, heritability, and structural variants such as inversions, copy number variants, genetic mosaicisms, and recombination histories. By reviewing recently published applications of these methods, the article describes the main characteristics of R packages, command-line tools, and desktop applications, both free and commercial, to maximize the utilization of publicly available SNP data.

BRIEFINGS IN BIOINFORMATICS (2022)

添加到收藏夹

Article Oncology

Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine

Laetitia Seguin et al.

Summary: Lung cancer, particularly adenocarcinoma, is a major global health concern. Understanding the cell of origin and molecular changes during tumor progression in adenocarcinoma is crucial for developing effective therapeutic strategies.

CANCERS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?

Henrike Bruckmueller et al.

Summary: Despite significant efforts, studies on genetic variants in ABC efflux transporters have shown weak associations with drug pharmacokinetics and response. Majority of studies have failed to confirm earlier findings and remain inconsistent. The impact of genetic variants on drug bioavailability is minor, with other factors regulating transporter expression and function being more critical. Overall, these genetic variants are not suitable as predictive biomarkers.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells

Giulia De Conti et al.

Summary: Drug resistance is a major obstacle in cancer therapy, with drug-tolerant persister cells playing a key role in resisting treatment. Designing specific therapies to prevent drug resistance development is a challenge, focusing on the characteristics and evolution of these drug-tolerant persister cells.

CANCERS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies

Smarakan Sneha et al.

Summary: Advances in treatment strategies for breast cancer face challenges in achieving selective treatment with limited side effects; The CYP family of enzymes play important roles in cancer cell proliferation, cell signaling, and drug metabolism, impacting treatment outcomes; Understanding CYP expression and its role in metabolizing steroid hormones and xenobiotics is crucial for the pathogenesis of breast cancer.

BIOMEDICINES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Roles of CYP3A4, CYP3A5 and CYP2C8 drug-metabolizing enzymes in cellular cytostatic resistance

Jakub Hofman et al.

Summary: Metabolic deactivation by cytochrome P450 (CYP) might be a significant mechanism of resistance to docetaxel, while the resistance to paclitaxel and vincristine is not influenced by CYP enzymes. These findings could provide valuable insights for future in vivo studies investigating intratumoural metabolism-based drug resistance.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

添加到收藏夹

Article Genetics & Heredity

Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)

Erin Rooney Riggs et al.

GENETICS IN MEDICINE (2020)

添加到收藏夹

Review Oncology

Drug-metabolizing enzymes: role in drug resistance in cancer

G. Kaur et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis

Fengying Liu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

添加到收藏夹

Review Oncology

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes

Maarten van Eijk et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

The ENCODE Blacklist: Identification of Problematic Regions of the Genome

Haley M. Amemiya et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Oncology

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma

Xiaohong Han et al.

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Article Biochemical Research Methods

A systematic evaluation of copy number alterations detection methods on real SNP array and deep sequencing data

Fei Luo

BMC BIOINFORMATICS (2019)

添加到收藏夹

Review Oncology

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy

Zuan-Fu Lim et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure

Lauren A. Marcath et al.

PHARMACOGENOMICS (2019)

添加到收藏夹

Review Oncology

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Cytochrome P450 Structure, Function and Clinical Significance: A Review

Palrasu Manikandan et al.

CURRENT DRUG TARGETS (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia

Alexander V. Lavrov et al.

PLOS ONE (2017)

添加到收藏夹

Article Oncology

The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma

Mao Qixing et al.

TUMOR BIOLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects

Y. Zhou et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Article Oncology

RECIST 1.1-Update and clarification: From the RECIST committee

Lawrence H. Schwartz et al.

EUROPEAN JOURNAL OF CANCER (2016)

添加到收藏夹

Article Oncology

Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol

Yan Chen et al.

CANCER MEDICINE (2016)

添加到收藏夹

Review Oncology

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

Anna Maria Barbuti et al.

CANCERS (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Ulrich M. Zanger et al.

PHARMACOLOGY & THERAPEUTICS (2013)

添加到收藏夹

Article Genetics & Heredity

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer

T. K. Bergmann et al.

PHARMACOGENOMICS JOURNAL (2011)

添加到收藏夹

Article Genetics & Heredity

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

S. Leskelae et al.

PHARMACOGENOMICS JOURNAL (2011)

添加到收藏夹

Review Genetics & Heredity

Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment

Cristina Rodriguez-Antona et al.

HUMAN GENETICS (2010)

添加到收藏夹

Article Multidisciplinary Sciences

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim et al.

NATURE (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Allele-specific copy number analysis of tumors

Peter Van Loo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug-drug interactions

Yiwen Gao et al.

XENOBIOTICA (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacogenetic Studies of Paclitaxel in the Treatment of Ovarian Cancer

Henrik Green et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)

添加到收藏夹

Article Oncology

Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients:: A study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group

Markus Joerger et al.

CLINICAL CANCER RESEARCH (2007)

添加到收藏夹

Article Genetics & Heredity

Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer

S. Marsh et al.

PHARMACOGENOMICS JOURNAL (2007)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cytochrome P450 pharmacogenetics and cancer

C Rodriguez-Antona et al.

ONCOGENE (2006)

添加到收藏夹

Article Oncology

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel

A Henningsson et al.

CLINICAL CANCER RESEARCH (2005)

添加到收藏夹

Review Pharmacology & Pharmacy

Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance - Focus on tamoxifen, paclitaxel and imatinib metabolism

B Rochat

CLINICAL PHARMACOKINETICS (2005)

添加到收藏夹

Article Oncology

Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes

SC Nallani et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women

MD Floyd et al.

PHARMACOGENETICS (2003)

添加到收藏夹

Article Pharmacology & Pharmacy

Regioselective metabolism of taxoids by human CYP3A4 and 2C8: Structure-activity relationship

T Cresteil et al.

DRUG METABOLISM AND DISPOSITION (2002)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid

D Dai et al.

PHARMACOGENETICS (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.